Product Description
Tirzepatide | 50mg
Researching Metabolic Regulation and Dual Incretin Signaling
What It Does
Tirzepatide is a dual-action peptide that activates two appetite-control hormones at once, making it more powerful than single-hormone peptides for weight loss. It steadies blood sugar and reduces hunger while helping the body use fat for energy more efficiently.
What Researchers Explore
- Appetite regulation and satiety signaling
- Glucose control and insulin response pathways
- Dual incretin receptor (GIP/GLP-1) activity
- Energy utilization and metabolic efficiency
- Body composition and weight regulation
- Cardiometabolic signaling pathways
Technical Background
Tirzepatide (LY3298176) is a 39-amino acid peptide engineered as a dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It includes a fatty diacid side chain that promotes albumin binding, extending its half-life to approximately 5 days.
Research indicates that combined receptor activation may produce synergistic effects on glucose regulation, appetite signaling, and metabolic pathways. These mechanisms are associated with modulation of insulin sensitivity, energy balance, and lipid metabolism.
Common Research Applications
- Dual incretin receptor signaling research
- Glucose homeostasis and insulin pathway studies
- Appetite and satiety regulation research
- Energy metabolism and expenditure studies
- Cardiometabolic parameter research
- Long-acting peptide pharmacokinetics
Product Properties
Purity: 99%+ HPLC
Form: Lyophilized Powder
Size: 10mg
Molecular Weight: ~4,800 Da
Amino Acids: 39
Category: Metabolic / Mitochondrial Research
Frequently Studied Together
- Semaglutide (GLP-1 receptor research)
- Retatrutide (triple receptor metabolic research)
- Cagrilintide (amylin pathway research)